Skip to content

Epidemiology and Clinical Characteristics of Hidradenitis Suppurativa in the Chinese Population: A Large-Scale Multicenter Study

Epidemiology and Clinical Characteristics of Hidradenitis Suppurativa in the Chinese Population: A Large-Scale Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127335
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis suppurativa mainly presents as deep, painful inflammatory nodules, abscesses, sinus tracts, and scarring in areas rich in apocrine glands such as the axillae, groin, and buttocks.

Interventions

Observation group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Time frame: Patients who attended the Department of Dermatology at participating centers between January 1, 2025, and December 31, 2025. 2. Diagnostic criteria: A confirmed diagnosis of hidradenitis suppurativa (HS) made by a dermatologist, meeting typical clinical manifestations (deep-seated nodules, abscesses, sinus tracts, scarring), typical anatomical sites (axillae, groin, anogenital/gluteal region, inframammary folds, etc.), and a chronic recurrent course; or a confirmed diagnosis of HS-associated syndromes (e.g., PASH, PAPA, PAPASH, follicular occlusion triad, follicular occlusion tetrad, etc.). 3. Data availability: Possession of traceable medical records containing at least the diagnosis name and date of visit.

Exclusion criteria

Exclusion criteria: 1. Patients with a definite diagnosis of a non-HS disease and without evidence of coexisting HS. 2.(2) Patients with only a single visit record and whose medical record description does not support chronic/recurrent features, and who cannot be confirmed upon expert review. 3.(3) Patients lacking critical information that precludes the description of baseline characteristics.

Design outcomes

Primary

MeasureTime frame
Disease history: Disease course, time of diagnosis, family history;;Severity of the disease: Hurley stage, IHS4 score, VAS score;;Location and morphology of skin lesions;Previous treatment history: Topical/oral medications, biological agents, surgical and other treatment histories.;Demography and lifestyle: Place of residence (accurate to province), gender, age, smoking history, drinking history, BMI (accurate to one decimal place), etc.;complication;

Countries

China

Contacts

Public ContactLiu Yang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

bengpao82@163.com+86 27 85768188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026